SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Effect of Financial Risk Taking on Profitability in the Pharmaceutical Industry
15 references·0 citing·44 second hop
The Effect of Financial Risk Taking on Profitability in the Pharmaceutical Industry (2021)The Effect of Financial Risk Taking on Pr…The capital structure of agricultural enterprises in the Visegrad countries (2020)The capital structure of agri…Influence of some financial indicators on return on equity ratio in the Romanian energy sector - A competitive approach using a DuPont-based analysis (2019)Influence of some financial i…Quantitative Methods for the Social Sciences (2018)Quantitative Methods for the …Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Innovation in the pharmaceuti…The evolution of the pharmaceutical industry (2015)The evolution of the pharmace…Accounting for Derivatives (2015)Accounting for DerivativesIAS 39 reclassification choice and analyst earnings forecast properties (2013)IAS 39 reclassification choic…Drug discovery in pharmaceutical industry: productivity challenges and trends (2012)Drug discovery in pharmaceuti…Lessons from 60 years of pharmaceutical innovation (2009)Lessons from 60 years of phar…The cost of biopharmaceutical R&D: is biotech different? (2007)The cost of biopharmaceutical…The Changing Structure Of The Pharmaceutical Industry (2004)The Changing Structure Of The…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Strategic trends in the drug industry (2003)Strategic trends in the drug …The Link Between Gross Profitability And Pharmaceutical R&D Spending (2001)The Link Between Gross Profit…Finance Theory and Financial Strategy (1984)Finance Theory and Financial …Economic Welfare and the Allocation of Resources for Invention (1962)An Evolutionary Theory of Economic Change. (1983)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1986)Documenting the financialisation of the pharmaceutical industry (2020)A dynamic multi-sector analysis of technological catch-up: The impact of technology cycle times, knowledge base complexity and variety (2021)The pharmaceutical productivity gap – Incremental decline in R&D efficiency despite transient improvements (2024)The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries (1968)Demand-Pull and Technological Invention: Schmookler Revisted (1982)R & D and Internal Finance: A Panel Study of Small Firms in High-Tech Industries (1994)Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price (2002)Economics of the Pharmaceutical Industry (2018)Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology (1996)The black swan: the impact of the highly improbable (2007)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Can the pharmaceutical industry reduce attrition rates? (2004)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Mitigating risk in academic preclinical drug discovery (2015)The changing model of big pharma: impact of key trends (2015)Exploring the impact of open innovation on firm performances (2016)Principles of Corporate Finance. (1981)Cost of innovation in the pharmaceutical industry (1991)Clinical development success rates for investigational drugs (2014)Stocks, bonds, bills, and inflation yearbook (1993)Risks in new drug development: Approval success rates for investigational drugs (2001)The Matthew Effect in Science (1968)The Matthew effect in science. The reward and communication systems of science are considered. (1968)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Comment on ???The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development??? (2005)The Patents-Based Pharmaceutical Development Process (2005)An Improved Approach To Measuring Drug Innovation Finds Steady Rates Of First-In-Class Pharmaceuticals, 1987–2011 (2013)Managing as if Tomorrow Mattered (1982)Stocks, bonds, bills, and inflation : the past and the future (1982)Assessing Advantage: A Framework for Diagnosing Competitive Superiority (1988)Joint Ventures and the Option to Expand and Acquire (1991)A general framework for analysing diversity in science, technology and society (2007)Financial statement analysis (2007)Cost-Effectiveness in Health and Medicine (1996)Essential medicines for universal health coverage (2016)The High Cost of Prescription Drugs in the United States (2016)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Funding Sustainable Online News: Sources of Revenue in Digital-Native and Traditional Media in Spain (2021)Impact of COVID-19 pandemic on mobility in ten countries and associated perceived risk for all transport modes (2021)The mediating role of technological vigilance between IT infrastructure and AIS efficiency (2024)
this work references cited by second hop

References

  • 2003The price of innovation: new estimates of drug development costs4,312 cited
  • 2016Innovation in the pharmaceutical industry: New estimates of R&D costs3,621 cited
  • 2009Lessons from 60 years of pharmaceutical innovation1,238 cited
  • 1984Finance Theory and Financial Strategy818 cited
  • 2007The cost of biopharmaceutical R&D: is biotech different?517 cited
  • 2012Drug discovery in pharmaceutical industry: productivity challenges and trends478 cited
  • 2018Quantitative Methods for the Social Sciences304 cited
  • 2001The Link Between Gross Profitability And Pharmaceutical R&D Spending183 cited
  • 2015The evolution of the pharmaceutical industry177 cited
  • 2004The Changing Structure Of The Pharmaceutical Industry172 cited
  • 2003Strategic trends in the drug industry165 cited
  • 2019Influence of some financial indicators on return on equity ratio in the Romanian energy sector - A competitive approach using a DuPont-based analysis82 cited
  • 2020The capital structure of agricultural enterprises in the Visegrad countries36 cited
  • 2015Accounting for Derivatives33 cited
  • 2013IAS 39 reclassification choice and analyst earnings forecast properties32 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

No citing works inside the corpus for this window.